Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Raskob

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Circulation|July 4, 2001
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacementA Lee, G Agnelli, H Büller, et al.
The New England Journal of Medicine|October 31, 2003
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolismH R Büller, B L Davidson, H Decousus, et al.
Thrombosis Research|November 17, 2019
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer studyF I Mulder, N van Es, N Kraaijpoel, et al.
Thrombosis Research|March 11, 2020
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19]F I Mulder, N van Es, N Kraaijpoel, et al.
International Angiology : a Journal of the International Union of Angiology|January 10, 2014
Prevention and treatment of venous thromboembolism--International Consensus StatementA N Nicolaides, J Fareed, A K Kakkar, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Circulation|July 4, 2001
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacementA Lee, G Agnelli, H Büller, et al.
The New England Journal of Medicine|October 31, 2003
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolismH R Büller, B L Davidson, H Decousus, et al.
Thrombosis Research|November 17, 2019
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer studyF I Mulder, N van Es, N Kraaijpoel, et al.
Thrombosis Research|March 11, 2020
Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19]F I Mulder, N van Es, N Kraaijpoel, et al.
International Angiology : a Journal of the International Union of Angiology|January 10, 2014
Prevention and treatment of venous thromboembolism--International Consensus StatementA N Nicolaides, J Fareed, A K Kakkar, et al.
Pageof 3